KLK3 and neoplasm: This suggests that given the information from the GC test, presumably measuring the true biological potential of a patient's tumor, urologists are more willing to commit to the intensification of therapy than if this recommendation were solely based on rising PSA and clinical variables (i.e., pre-GC).